Philippe Martin
Technik-/Wissenschafts-/F&E-Leiter bei VIATRIS INC.
Profil
Philippe Martin is currently the Chief Research & Development Officer at Viatris, Inc. He previously worked as the VP Project Leadership & Project Management at Celgene Corp from 2009 to 2016 and as the Chief Clinical Development & Operations Officer at BioAtla, Inc. from 2018 to 2023.
Mr. Martin holds an MBA from EM Lyon Business School.
Aktive Positionen von Philippe Martin
| Unternehmen | Position | Beginn |
|---|---|---|
| VIATRIS INC. | Technik-/Wissenschafts-/F&E-Leiter | 15.12.2023 |
Ehemalige bekannte Positionen von Philippe Martin
| Unternehmen | Position | Ende |
|---|---|---|
| BIOATLA, INC. | Geschäftsführer | 01.09.2023 |
| CELGENE | Corporate Officer/Principal | 04.06.2016 |
Ausbildung von Philippe Martin
| EM Lyon Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIOATLA, INC. | Health Technology |
| VIATRIS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
